Buscar en
Revista Española de Medicina Legal
Toda la web
Inicio Revista Española de Medicina Legal A proper SARS-CoV-2 risk assessment is needed for medico-legal assessment of the...
Información de la revista
Vol. 47. Núm. 3.
Páginas 130-131 (Julio - Septiembre 2021)
Descargar PDF
Más opciones de artículo
Vol. 47. Núm. 3.
Páginas 130-131 (Julio - Septiembre 2021)
Letter to the Editor
Acceso a texto completo
A proper SARS-CoV-2 risk assessment is needed for medico-legal assessment of the COVID-19 infection
Se necesita una evaluación adecuada del riesgo de SARS-CoV-2 para la evaluación médico-legal de la infección por COVID-19
Francesco Chiricoa,
Autor para correspondencia

Corresponding author.
, Giuseppe Tainob
a Contract Professor, Post-graduate School of Occupational Medicine, Università Cattolica del Sacro Cuore, Rome, Italy
b “IRCCS S. Maugeri”, Foundation-Pavia-Unit Hospital of Occupational Medicine (UOOML), Pavia, Italy
Este artículo ha recibido
Información del artículo
Texto completo
Descargar PDF
Texto completo
Dear Editor,

The valuable paper by Marti-Amengual et al.1 raises some critical aspects worthy to be addressed. In Italy, COVID-19 infection is considered as an occupational injury,2 not only in healthcare workers (HCWs) of private and public hospitals, and when it occurs while travelling to or from work, as stated by authors. COVID-19 infection is, indeed, considered by the Italian National Institute for Insurance against Accidents at Work (INAIL), as a biological injury in all types of workers in contact with the public (e.g. social workers, every type of worker employed at hospitals, cashiers, grocery staff, etc.), as well as in frontline workers. For all the above categories of workers, there is a legal presumption of professional cause, and this can immediately allow the provision of insurance benefits, whereas the cause-effect relationship can nevertheless be demonstrated case by case by the worker applying for compensation in all other cases.3 In Italy, there is a “mixed system”, for which occupational diseases, even caused by biological agents, are considered to be not only those listed in the reference tables established by specific laws, but also any other illness which the employee can prove is connected to his or her professional activity. The causal relationship between exposure to SARS-CoV-2 and COVID-19 infection, however, may be impossible to be proven in conditions of high circulation of the epidemic.2,4 For this reason, the risk assessment carried out by each employers becomes crucial for a proper medico-legal evaluation aimed to worker's compensation. In Italy, INAIL developed a risk assessment strategy for evaluating SARS-CoV-2 infection, which consists of a risk matrix based on a combination of three important factors, namely the exposure to infected people, the physical proximity to others during work activities, and the social aggregation connected to the job. However, this strategy needs to be specifically adapted by individual employers to their own workplaces. As a consequence, employers should enhance preventive measures established by the Italian Government (DPCM of April 26, 2020 and subsequent modifications and integrations).5 The classification of biological agents by European Directive 2000/54/CE is a fundamental prerequisite for the hazard identification, the first step for evaluating any biological agents at workplace. SARS-CoV-2 has been recently included in the third group of occupational biohazard owing the fact the preventive measures are supposed to exist.1 However, we agree with who disagreed and called for a group 4 categorisation.6,7 Indeed, the increasingly number of HCWs infected during the second Italian wave (91,711 HCWs affected as of December 30, 2020, in Italy),8,9 showed how, in absence of vaccination, there is no still effective prophylaxis to prevent COVID-19 infection. This risk misclassification could also be the reason for this high number of occupational injuries.10

Authors’ contribution

FC drafted and GT revised the paper. Both the authors accepted the final version of the paper.

Financial support

None reported.

Conflicts of interest

All authors report no conflicts of interest relevant to this article.

G. Marti-Amengual, P. Sanz-Gallen, J. Arimany-Manso.
Medico-legal assessment of the COVID-19 infection in workplace.
Span J Leg Med, 46 (2020), pp. 146-152
F. Chirico, N. Magnavita.
Covid-19 infection in Italy: an occupational injury.
S Afr Med J, 110 (2020), pp. 436
Ministry of Health, Italy. INAIL. Covid-19, per i contagi sul lavoro garantite le stesse prestazioni degli infortuni. Circolare Inail n. 13 del 3 aprile 2020. https://www.inail.it/cs/internet/comunicazione/sala-stampa/comunicati-stampa/com-stampa-circolare-3-aprile-contagi-covid-19-2020.html [accessed 15.01.21].
F. Chirico, G. Nucera, N. Magnavita.
Estimating case fatality ratio during COVID-19 epidemics: pitfalls and alternatives.
J Infect Dev Ctries, 14 (2020), pp. 438-439
INAIL. Documento tecnico sulla possibile rimodulazione delle misure di contenimento del contagio da SARS-CoV-2 nei luoghi di lavoro e strategie di prevenzione. Available from: Documento tecnico sulla possibile rimodulazione delle misure di contenimento del contagio da SARS-CoV-2 nei luoghi di lavoro e strategie di prevenzione – INAIL. Last update 23.04.20.
Guarascio F. Coronavirus is not high threat to workers, EU says, causing outcry. Date: June 3, 2020. Available from: https://www.reuters.com/article/us-health-coronavirus-eu-workers/coronavirus-is-not-high-threat-to-workers-eu-says-idUSKBN23A1H9 [accessed 15.01.21].
F. Chirico, N. Magnavita.
The crucial role of occupational health surveillance for health-care workers during the COVID-19 pandemic.
Workplace Health Saf, 69 (2021), pp. 5-6
F. Chirico, G. Nucera.
Tribute to healthcare operators threatened by COVID-19 pandemic.
J Health Soc Sci, 5 (2020), pp. 165-168
Italian Institute of Health SARS-CoV-2 epidemiological data section; Last update: 30 December 2020. Available from: https://www.epicentro.iss.it/coronavirus/sars-cov-2-dashboard [accessed 31.12.20].
J.M. Hernández.
SARS-CoV-2 risk misclassification explains poor COVID-19 management.
Lancet, 396 (2020), pp. 1733-1734
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos